Valuation: OneSource Specialty Pharma Limited

Market Cap 179B 1.87B 1.61B 1.52B 1.38B 2.59B 2.64B 17.78B 6.95B 89.52B 7.02B 6.87B 297B P/E 2026
-229x
P/E 2027 * 38.5x
Enterprise Value 190B 1.98B 1.71B 1.61B 1.46B 2.75B 2.8B 18.85B 7.37B 94.93B 7.44B 7.28B 315B EV / Sales 2026
12.7x
EV / Sales 2027 * 8.61x
Free-Float
61.97%
Yield 2026 *
-
Yield 2027 * -
1 day-0.77%
1 week-1.07%
Current month-3.74%
1 month-4.93%
3 months-15.02%
6 months+31.56%
Current year-13.88%
1 week 1,527.1
Extreme 1527.1
1,647
1 month 1,506.7
Extreme 1506.7
1,755.2
Current year 1,057
Extreme 1057
1,917.8
1 year 1,057
Extreme 1057
1,925
3 years 1,057
Extreme 1057
2,248
5 years 1,057
Extreme 1057
2,248
10 years 1,057
Extreme 1057
2,248
Manager TitleAgeSince
Chief Executive Officer 54 29/02/2024
Director of Finance/CFO - 03/07/2024
Compliance Officer - 13/03/2023
Director TitleAgeSince
Director/Board Member 65 06/04/2021
Director/Board Member 54 29/02/2024
Director/Board Member 66 26/02/2025
Change 5-day change 1-year change 3-year change Capi.($)
-0.77%-1.07%-16.94% - 1.87B
-1.78%-1.68%+1.48%+15.31% 48.42B
+0.85%-0.70%+460.88%+563.55% 43.66B
-2.40%-0.23%+8.13%+71.41% 39.51B
-2.01%-0.85%+23.85%+8.73% 38.95B
-0.50%+0.85%+20.60%+49.65% 32.61B
+0.38%-3.23% - - 16.32B
-0.59%-2.06%+26.35%+118.09% 16.15B
+0.49%+0.92%+4.11%+23.67% 14.16B
-0.43%+4.70%+78.74%+33.31% 13.37B
Average -0.68%+0.53%+67.47%+110.46% 26.5B
Weighted average by Cap. -0.91%+0.59%+94.98%+132.95%

Financials

2026 2027 *
Net sales 13.41B 140M 121M 114M 104M 195M 198M 1.33B 522M 6.72B 527M 515M 22.32B 21.8B 228M 197M 185M 168M 316M 322M 2.17B 848M 10.92B 856M 837M 36.28B
Net income -1.19B -12.45M -10.75M -10.1M -9.19M -17.27M -17.56M -118M -46.29M -596M -46.74M -45.72M -1.98B 4.46B 46.63M 40.28M 37.85M 34.42M 64.71M 65.78M 443M 173M 2.23B 175M 171M 7.42B
Net Debt 10.81B 113M 97.61M 91.73M 83.42M 157M 159M 1.07B 420M 5.41B 424M 415M 17.98B 8.86B 92.61M 79.99M 75.17M 68.36M 129M 131M 881M 344M 4.43B 348M 340M 14.74B
Logo OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The Company specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The Company caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.
Employees
1,412
Date Price Change Volume
14/08/26 ₹1,559.20 -0.77% 239,351
13/08/26 ₹1,571.30 +2.09% 98,933
12/08/26 ₹1,539.20 -3.73% 135,574
11/08/26 ₹1,598.90 +1.49% 356,777
10/08/26 ₹1,575.40 -0.04% 230,127
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,559.20INR
Average target price
2,056.00INR
Spread / Average Target
+31.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ONESOURCE Stock